201 related articles for article (PubMed ID: 22417321)
1. Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen.
Katz ML; Volkening LK; Anderson BJ; Laffel LM
Diabet Med; 2012 Jul; 29(7):926-32. PubMed ID: 22417321
[TBL] [Abstract][Full Text] [Related]
2. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
3. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
4. Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
Karges B; Tittel SR; Bey A; Freiberg C; Klinkert C; Kordonouri O; Thiele-Schmitz S; Schröder C; Steigleder-Schweiger C; Holl RW
Lancet Diabetes Endocrinol; 2023 May; 11(5):314-323. PubMed ID: 37004710
[TBL] [Abstract][Full Text] [Related]
5. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
[TBL] [Abstract][Full Text] [Related]
6. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycaemia during pregnancy in women with Type 1 diabetes.
Ringholm L; Pedersen-Bjergaard U; Thorsteinsson B; Damm P; Mathiesen ER
Diabet Med; 2012 May; 29(5):558-66. PubMed ID: 22313112
[TBL] [Abstract][Full Text] [Related]
8. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
[TBL] [Abstract][Full Text] [Related]
10. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
UK Hypoglycaemia Study Group
Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
[TBL] [Abstract][Full Text] [Related]
11. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
Hope SV; Knight BA; Shields BM; Hill AV; Choudhary P; Strain WD; McDonald TJ; Jones AG
Diabetologia; 2018 Jan; 61(1):66-74. PubMed ID: 28983693
[TBL] [Abstract][Full Text] [Related]
12. The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
Agesen RM; Alibegovic AC; Andersen HU; Beck-Nielsen H; Gustenhoff P; Hansen TK; Hedetoft C; Jensen T; Juhl CB; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
BMC Endocr Disord; 2019 Jul; 19(1):78. PubMed ID: 31337371
[TBL] [Abstract][Full Text] [Related]
13. Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?
Heller SR; Amiel SA; Evans ML; Kong MF; Macdonald IA; Peacey SR
Diabetes Obes Metab; 2002 Mar; 4(2):106-12. PubMed ID: 11940107
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.
Smeeton F; Shojaee Moradie F; Jones RH; Westergaard L; Haahr H; Umpleby AM; Russell-Jones DL
Diabetologia; 2009 Nov; 52(11):2317-23. PubMed ID: 19707744
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic hypoglycaemia in Type 1 diabetes: incidence and risk factors.
Henriksen MM; Andersen HU; Thorsteinsson B; Pedersen-Bjergaard U
Diabet Med; 2019 Jan; 36(1):62-69. PubMed ID: 30368899
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes.
Cooper MN; O'Connell SM; Davis EA; Jones TW
Diabetologia; 2013 Oct; 56(10):2164-70. PubMed ID: 23832082
[TBL] [Abstract][Full Text] [Related]
17. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
18. Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative review.
Russell-Jones D; Bailey TS; Lane W; Mathieu C; Pedersen-Bjergaard U
Diabet Med; 2024 Jul; 41(7):e15339. PubMed ID: 38679910
[TBL] [Abstract][Full Text] [Related]
19. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
